| Characteristic | Consumption in DDD per 1,000 population |
|---|---|
| Penicillins (excluding inhibitors) | 5.76 |
| Tetracyclines | 4.55 |
| Macrolides, lincosamides and streptogramins | 2.35 |
| Other antibacterials | 1.88 |
| Penicillins (inhibitor combinations only) | 1.09 |
| Sulfonamides and trimethoprim | 0.78 |
| Quinolone antibacterials | 0.45 |
| First and second-generation cephalosporins | 0.27 |
| Oral metronidazole | 0.27 |
| Aminoglycosides | 0.09 |
| Third, fourth and fifth-generation celphalosporins | 0.08 |
| Carbapenems | 0.05 |
| Anti-Clostridioides difficile agents | 0.01 |
| Amphenicols | 0 |
The chart is not accessible to screen readers. Please switch to the table view to access the data.
Loading statistic...
Download
Source
More information
Region
United Kingdom (England)
Survey time period
2023
Supplementary notes
Consumption in primary and secondary care.
DDD is the defined daily dose.
Data rounded to two decimal points.
This statistic is using original data from the Department of Health and includes copyright material from © Crown, licensed under the
Citation formats
